Showing results (1-10 of 248) with videos related to
Sort By:
Pageof 25
Journal of Neurology|July 29, 2003
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosisPaola Perini, Paolo GalloMultiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
A case of relapsing-remitting tumour-like inflammation of the central nervous systemSilvia Miante, Paola Perini, Francesca Rinaldi, et al.Journal of Neurology|March 12, 2004
The clinical impact of interferon beta antibodies in relapsing-remitting MSPaola Perini, Massimiliano Calabrese, Giovanni Biasi, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Cyclophosphamide-based combination therapies for autoimmunityPaola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.Expert Opinion on Drug Safety|March 21, 2007
The safety profile of cyclophosphamide in multiple sclerosis therapyPaola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.Frontiers in Neurology|June 3, 2021
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and OpportunitiesMonica Margoni, Francesca Rinaldi, Paola Perini, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Relapsing tumefactive demyelination lesions: A unique, distinct inflammatory brain pathologyPaola Perini, Marta Gaggiola, Francesca Rinaldi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2009
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosisFrancesca Rinaldi, Paola Perini, Massimiliano Calabrese, et al.Annals of Neurology|February 1, 2011
No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onsetClaudio Baracchini, Paola Perini, Massimiliano Calabrese, et al.Therapeutic Advances in Neurological Disorders|February 6, 2018
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenonMarco Puthenparampil, Francesca Rinaldi, Lisa Federle, et al.Pageof 25